
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $4.1B | $4.7B | $5.5B | $5.9B | $6.3B | |
Revenue Growth (YoY) | -3.44% | 15.48% | 15.67% | 7.87% | 6.1% | |
Cost of Revenues | $1.3B | $1.4B | $1.7B | $1.9B | $2B | |
Gross Profit | $2.8B | $3.3B | $3.8B | $4B | $4.2B | |
Gross Profit Margin | 67.19% | 69.5% | 69.07% | 67.78% | 67.72% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2B | $2.2B | $2.5B | $2.7B | $2.9B | |
Other Inc / (Exp) | -$56.8M | $164.7M | $39.3M | $130.3M | $299.6M | |
Operating Expenses | $2.3B | $2.4B | $2.7B | $2.9B | $3.1B | |
Operating Income | $496.4M | $921.8M | $1.1B | $1.1B | $1.2B | |
Net Interest Expenses | $113.5M | $116.6M | $121.3M | $94.2M | $69.5M | |
EBT. Incl. Unusual Items | $326.1M | $969.9M | $1B | $1.1B | $1.4B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $59.4M | $176.3M | $219.4M | $264.7M | $133.7M | |
Net Income to Company | $266.7M | $793.6M | $807.8M | $882.5M | $1.3B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $266.7M | $793.6M | $807.8M | $882.5M | $1.3B | |
Basic EPS (Cont. Ops) | $2.99 | $9.33 | $10.08 | $11.17 | $16.12 | |
Diluted EPS (Cont. Ops) | $2.96 | $9.21 | $9.96 | $11.08 | $16.00 | |
Weighted Average Basic Share | $89.3M | $85M | $80.2M | $79M | $77.8M | |
Weighted Average Diluted Share | $90M | $86.2M | $81.1M | $79.7M | $78.3M | |
EBITDA | $660.8M | $1.3B | $1.3B | $1.5B | $1.7B | |
EBIT | $441.8M | $1.1B | $1.2B | $1.3B | $1.5B | |
Revenue (Reported) | $4.1B | $4.7B | $5.5B | $5.9B | $6.3B | |
Operating Income (Reported) | $496.4M | $921.8M | $1.1B | $1.1B | $1.2B | |
Operating Income (Adjusted) | $441.8M | $1.1B | $1.2B | $1.3B | $1.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.1B | $1.3B | $1.4B | $1.5B | $1.5B | |
Revenue Growth (YoY) | 8.36% | 14.38% | 11.57% | 4.55% | 4.16% | |
Cost of Revenues | $334.5M | $377M | $435.1M | $459.4M | $475M | |
Gross Profit | $769.6M | $885.7M | $973.7M | $1B | $1.1B | |
Gross Profit Margin | 69.71% | 70.14% | 69.11% | 68.81% | 69.04% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $487.3M | $617.9M | $657.1M | $689.8M | $730.3M | |
Other Inc / (Exp) | $14.9M | $27M | $138.7M | $4.4M | $2.4M | |
Operating Expenses | $543.5M | $666.3M | $703.7M | $739.1M | $781.1M | |
Operating Income | $226.1M | $219.5M | $270M | $274.3M | $278M | |
Net Interest Expenses | $26.1M | $31.4M | $27.4M | $19.2M | $13.4M | |
EBT. Incl. Unusual Items | $214.8M | $215.1M | $381.3M | $259.6M | $267M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $50.7M | $42.5M | $85.5M | $49M | $56.1M | |
Net Income to Company | $164.1M | $172.5M | $295.8M | $210.5M | $210.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $164.1M | $172.5M | $295.8M | $210.5M | $210.9M | |
Basic EPS (Cont. Ops) | $1.86 | $2.10 | $3.72 | $2.69 | $2.73 | |
Diluted EPS (Cont. Ops) | $1.84 | $2.08 | $3.68 | $2.67 | $2.71 | |
Weighted Average Basic Share | $88.4M | $82M | $79.5M | $78.3M | $77.4M | |
Weighted Average Diluted Share | $89.1M | $83M | $80.3M | $79M | $77.8M | |
EBITDA | $297.2M | $294.8M | $455.3M | $328.1M | $331.2M | |
EBIT | $240.9M | $246.5M | $408.7M | $278.8M | $280.4M | |
Revenue (Reported) | $1.1B | $1.3B | $1.4B | $1.5B | $1.5B | |
Operating Income (Reported) | $226.1M | $219.5M | $270M | $274.3M | $278M | |
Operating Income (Adjusted) | $240.9M | $246.5M | $408.7M | $278.8M | $280.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $4.2B | $4.9B | $5.6B | $6B | $6.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.3B | $1.5B | $1.8B | $1.9B | $2B | |
Gross Profit | $2.8B | $3.4B | $3.9B | $4B | $4.3B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2B | $2.3B | $2.5B | $2.7B | $2.9B | |
Other Inc / (Exp) | -$38.8M | $176.8M | $151M | -$3.9M | $297.6M | |
Operating Expenses | $2.3B | $2.5B | $2.7B | $2.9B | $3.1B | |
Operating Income | $596.2M | $915.2M | $1.2B | $1.1B | $1.2B | |
Net Interest Expenses | $113.4M | $121.9M | $117.3M | $86.1M | $63.7M | |
EBT. Incl. Unusual Items | $444M | $970.2M | $1.2B | $1B | $1.4B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $88.3M | $168.2M | $262.3M | $228.2M | $140.7M | |
Net Income to Company | $355.7M | $802M | $931.1M | $797.2M | $1.3B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $355.7M | $802M | $931.1M | $797.2M | $1.3B | |
Basic EPS (Cont. Ops) | $4.01 | $9.58 | $11.70 | $10.13 | $16.18 | |
Diluted EPS (Cont. Ops) | $3.97 | $9.47 | $11.59 | $10.05 | $16.07 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $780M | $1.3B | $1.5B | $1.3B | $1.7B | |
EBIT | $559.5M | $1.1B | $1.3B | $1.2B | $1.5B | |
Revenue (Reported) | $4.2B | $4.9B | $5.6B | $6B | $6.3B | |
Operating Income (Reported) | $596.2M | $915.2M | $1.2B | $1.1B | $1.2B | |
Operating Income (Adjusted) | $559.5M | $1.1B | $1.3B | $1.2B | $1.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.1B | $1.3B | $1.4B | $1.5B | $1.5B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $334.5M | $377M | $435.1M | $459.4M | $475M | |
Gross Profit | $769.6M | $885.7M | $973.7M | $1B | $1.1B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $487.3M | $617.9M | $657.1M | $689.8M | $730.3M | |
Other Inc / (Exp) | $14.9M | $27M | $138.7M | $4.4M | $2.4M | |
Operating Expenses | $543.5M | $666.3M | $703.7M | $739.1M | $781.1M | |
Operating Income | $226.1M | $219.5M | $270M | $274.3M | $278M | |
Net Interest Expenses | $26.1M | $31.4M | $27.4M | $19.2M | $13.4M | |
EBT. Incl. Unusual Items | $214.8M | $215.1M | $381.3M | $259.6M | $267M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $50.7M | $42.5M | $85.5M | $49M | $56.1M | |
Net Income to Company | $164.1M | $172.5M | $295.8M | $210.5M | $210.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $164.1M | $172.5M | $295.8M | $210.5M | $210.9M | |
Basic EPS (Cont. Ops) | $1.86 | $2.10 | $3.72 | $2.69 | $2.73 | |
Diluted EPS (Cont. Ops) | $1.84 | $2.08 | $3.68 | $2.67 | $2.71 | |
Weighted Average Basic Share | $88.4M | $82M | $79.5M | $78.3M | $77.4M | |
Weighted Average Diluted Share | $89.1M | $83M | $80.3M | $79M | $77.8M | |
EBITDA | $297.2M | $294.8M | $455.3M | $328.1M | $331.2M | |
EBIT | $240.9M | $246.5M | $408.7M | $278.8M | $280.4M | |
Revenue (Reported) | $1.1B | $1.3B | $1.4B | $1.5B | $1.5B | |
Operating Income (Reported) | $226.1M | $219.5M | $270M | $274.3M | $278M | |
Operating Income (Adjusted) | $240.9M | $246.5M | $408.7M | $278.8M | $280.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $712.6M | $756.5M | $698M | $1.3B | $1.9B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.2B | $1.4B | $1.6B | $1.6B | $1.7B | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $109.2M | $117.8M | $119.2M | $127.2M | $153.2M | |
Total Current Assets | $2.3B | $2.6B | $2.8B | $3.4B | $4.2B | |
Property Plant And Equipment | $984M | $821.8M | $701.2M | $629.5M | $500.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $2.9B | $3B | $2.9B | $2.9B | $2.9B | |
Other Intangibles | $807M | $714.4M | $584.7M | $502M | $409.7M | |
Other Long-Term Assets | $54.2M | $55.1M | $59.7M | $70.3M | $79.1M | |
Total Assets | $7.3B | $7.4B | $7.3B | $7.8B | $8.5B | |
Accounts Payable | $38.6M | $49.3M | $83.2M | $63.1M | $55.8M | |
Accrued Expenses | $351.8M | $483.4M | $390M | $387.7M | $470.4M | |
Current Portion Of Long-Term Debt | $20.5M | $5.9M | $7.8M | $9.6M | -- | |
Current Portion Of Capital Lease Obligations | $84M | $89.8M | $99.7M | $98.5M | $100.3M | |
Other Current Liabilities | $34.9M | -- | $30.8M | -- | -- | |
Total Current Liabilities | $2.9B | $3.4B | $3.6B | $3.8B | $4B | |
Long-Term Debt | $2B | $2.5B | $2.5B | $2.4B | $2.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $6.2B | $7B | $7.1B | $7.2B | $7.2B | |
Common Stock | $82K | $82K | $82K | $82K | $82K | |
Other Common Equity Adj | -$99.2M | -$81.4M | -$101.6M | -$76.3M | -$88.3M | |
Common Equity | $1.1B | $371.1M | $227.8M | $680.6M | $1.4B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $1.1B | $371.1M | $227.8M | $680.6M | $1.4B | |
Total Liabilities and Equity | $7.3B | $7.4B | $7.3B | $7.8B | $8.5B | |
Cash and Short Terms | $712.6M | $756.5M | $698M | $1.3B | $1.9B | |
Total Debt | $2B | $2.5B | $2.5B | $2.5B | $2.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $446M | $456.2M | $893.5M | $1.2B | $2.1B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.2B | $1.3B | $1.5B | $1.6B | $1.5B | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $118.5M | $131.3M | $142.7M | $173.8M | $159.9M | |
Total Current Assets | $2B | $2.3B | $2.9B | $3.3B | $4.1B | |
Property Plant And Equipment | $956.4M | $771.7M | $671.9M | $608.9M | $495.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $2.9B | $2.9B | $2.9B | $2.9B | $2.9B | |
Other Intangibles | $777.4M | $684.5M | $564.1M | $477.7M | $391.8M | |
Other Long-Term Assets | $262.7M | $306M | $309.6M | $362.5M | $527.2M | |
Total Assets | $6.9B | $7B | $7.4B | $7.7B | $8.5B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $2.8B | $3.3B | $3.5B | $3.6B | $3.8B | |
Long-Term Debt | $1.9B | $2.5B | $2.5B | $2.5B | $2.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $6B | $6.9B | $6.9B | $7B | $7B | |
Common Stock | $82K | $82K | $82K | $82K | $82K | |
Other Common Equity Adj | -$93.2M | -$82.8M | -$95.9M | -$82.4M | -$67.8M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $891.6M | $118.2M | $472.9M | $718.2M | $1.5B | |
Total Liabilities and Equity | $6.9B | $7B | $7.4B | $7.7B | $8.5B | |
Cash and Short Terms | $446M | $456.2M | $893.5M | $1.2B | $2.1B | |
Total Debt | $2B | $2.5B | $2.5B | $2.5B | $2.5B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $266.7M | $793.6M | $807.8M | $882.5M | $1.3B | |
Depreciation & Amoritzation | $219M | $212.4M | $191.9M | $191.1M | $202.3M | |
Stock-Based Compensation | $62.5M | $98.6M | $90.6M | $129.8M | $154.8M | |
Change in Accounts Receivable | $99.4M | -$145.3M | -$240.7M | -$24.7M | -$137.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $903.3M | $1.3B | $1.1B | $1.2B | $1.5B | |
Capital Expenditures | $83.9M | $59.8M | $108.1M | $103.1M | $101.7M | |
Cash Acquisitions | -- | -$22.9M | -$9.5M | $157.3M | -$2M | |
Cash From Investing | -$83.9M | -$80.5M | -$117.6M | $54.2M | -$103.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $2.3B | $600M | -- | -- | $274.4M | |
Long-Term Debt Repaid | -$2.6B | -$112.9M | -$5.9M | -$7.8M | -$274.4M | |
Repurchase of Common Stock | -$176.3M | -$1.7B | -$1B | -$606.2M | -$735.4M | |
Other Financing Activities | -$25.8M | -$7.3M | -- | -- | -$3M | |
Cash From Financing | -$416.2M | -$1.2B | -$1B | -$588.9M | -$710.1M | |
Beginning Cash (CF) | $280.8M | $712.6M | $760.6M | $698.6M | $1.3B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $403.2M | $74.4M | -$43.6M | $621M | $671M | |
Ending Cash (CF) | $712.6M | $760.6M | $698.6M | $1.3B | $1.9B | |
Levered Free Cash Flow | $819.4M | $1.3B | $993.4M | $1.1B | $1.4B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $271.2M | $204.9M | $198M | $229.5M | -- | |
Depreciation & Amoritzation | $52M | $47.7M | $46.6M | $50.5M | -- | |
Stock-Based Compensation | $26.2M | $24.5M | $32.2M | $39.7M | -- | |
Change in Accounts Receivable | $78.5M | $128.4M | $258.4M | $154.7M | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $575.3M | $415.6M | $435.8M | $370M | -- | |
Capital Expenditures | $12M | $21.1M | $25.6M | $29.4M | -- | |
Cash Acquisitions | -$22.8M | -- | -$2.7M | -- | -- | |
Cash From Investing | -$34.7M | -$21.1M | -$28.2M | -$29.4M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $600M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$100.1M | -$1.3M | -$1.8M | -- | -- | |
Repurchase of Common Stock | -$684.9M | -$478.8M | -$131.5M | -$339.6M | -- | |
Other Financing Activities | -$6M | -- | -- | -$368K | -- | |
Cash From Financing | -$187M | -$475.1M | -$127.4M | -$333.5M | -- | |
Beginning Cash (CF) | $446M | $460.3M | $894.1M | $1.2B | -- | |
Foreign Exchange Rate Adjustment | $864K | -$15.1M | -$778K | -$7.7M | -- | |
Additions / Reductions | $353.6M | -$80.6M | $280.1M | $7M | -- | |
Ending Cash (CF) | $800.5M | $364.6M | $1.2B | $1.2B | -- | |
Levered Free Cash Flow | $563.4M | $394.5M | $410.2M | $340.6M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $355.7M | $802M | $931.1M | $797.2M | $1.3B | |
Depreciation & Amoritzation | $220.6M | $204.5M | $190.2M | $193.8M | $203.8M | |
Stock-Based Compensation | $73.5M | $94.6M | $103.5M | $135.3M | $154.5M | |
Change in Accounts Receivable | $17.9M | -$168.8M | -$235.2M | -$42.6M | $55.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $1B | $1.3B | $1.1B | $1.2B | $1.6B | |
Capital Expenditures | $71.9M | $64.6M | $111.9M | $104.7M | $104.6M | |
Cash Acquisitions | -- | -$22.9M | $149.2M | -$3.5M | -- | |
Cash From Investing | -$71.9M | -$85.2M | $37.3M | -$108.1M | -$104.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $274.4M | -- | |
Long-Term Debt Repaid | -$2.5B | -$104.1M | -$6.4M | -$280.4M | -- | |
Repurchase of Common Stock | -$501.6M | -$1.7B | -$699.5M | -$724.5M | -$672.9M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$751M | -$1.2B | -$683.3M | -$707.3M | -$643.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $182M | $37.9M | $452.4M | $364.5M | $861.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $933M | $1.3B | $986.4M | $1.1B | $1.5B |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $435.3M | $377.4M | $493.8M | $440.1M | $210.9M | |
Depreciation & Amoritzation | $108.3M | $96M | $93.2M | $99.8M | $50.8M | |
Stock-Based Compensation | $62.3M | $56.6M | $77.3M | $90.2M | $50.2M | |
Change in Accounts Receivable | $132.7M | $159.1M | $294.6M | $172.9M | $211.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $732.6M | $583.4M | $600.5M | $558.8M | $313.5M | |
Capital Expenditures | $24.5M | $38.4M | $46.7M | $52M | $25.6M | |
Cash Acquisitions | -$22.8M | -- | $156.1M | -$2M | -- | |
Cash From Investing | -$47.3M | -$38.4M | $109.4M | -$54M | -$25.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $600M | -- | -- | $274.4M | -- | |
Long-Term Debt Repaid | -$110.3M | -$2.7M | -$3.6M | -$274.4M | -- | |
Repurchase of Common Stock | -$1.1B | -$929.9M | -$238.4M | -$564.7M | -$162.7M | |
Other Financing Activities | -$6M | -- | -- | -$3M | -- | |
Cash From Financing | -$590.2M | -$920.5M | -$228.7M | -$553.2M | -$152.9M | |
Beginning Cash (CF) | $1.2B | $1.2B | $1.6B | $2.6B | $1.9B | |
Foreign Exchange Rate Adjustment | -$7.3M | -$20.5M | -$6.3M | -$35.4M | $22.9M | |
Additions / Reductions | $95.2M | -$375.5M | $481.1M | -$48.5M | $135M | |
Ending Cash (CF) | $1.2B | $824.9M | $2.1B | $2.5B | $2.1B | |
Levered Free Cash Flow | $708.2M | $545M | $553.8M | $506.8M | $287.9M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.